PS-108-NGM, a novel activator of beta-Klotho/FGFR1c: A single dose significantly reduces steatosis (liver fat by MRI-PDFF), inflammation (ALT, AST) and fibrogenic activity (Pro-C3) in NAFLD subjects - DePaoli, Alex; Bashir, Mustafa; Phung, Van; Yan, Andrew; Ling, Lei; Baxter, Bryan; Tian, Hui (Journal of hepatology, 2019)